About Halewood Laboratories Private Limited
Data last updated: 18 January 2026
Halewood Laboratories Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 20 June 2000, the company has been in operation for over 26 years.
Registered with ROC Ahmedabad under CIN U24231GJ2000PTC038236.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹33 Lakh. It is led by directors including Sanchit Kaushik Chaturvedi and Kaushik Shantilal Chaturvedi.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2024. Office: 319 Gidc Industrial Estatephase Ii Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2025, the company reported a revenue of ₹430.29 Cr, a growth of 20% compared to the previous year.
The company has a workforce of approximately 473 employees as per the latest available data.
The company is associated with 1 brand - Halewood Laboratories. As per MCA filings, the company has open charges of ₹197.11 Cr and satisfied charges of ₹24.56 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website halewoodlabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address319 Gidc Industrial Estatephase Ii Vatva, Ahmedabad, Gujarat, India – 382445
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Halewood Laboratories Private Limited
Halewood Laboratories Private Limited operates one associated brand: Halewood Laboratories. These brands represent Halewood Laboratories Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | halewoodlabs.com |
Competitors & Alternatives of Halewood Laboratories Private Limited
Brands and companies operating in the same space as Halewood Laboratories Private Limited include Inventia Healthcare, Zim Labs, Lotus and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Inventia Healthcare
|
Oral solid drug delivery systems are manufactured and developed. | Mumbai, India, India | 1985 |
Zim Labs
|
Solid and semisolid dosage forms are developed and manufactured. | Nagpur, India, India | 1989 |
Lotus
|
Contract manufacturing for oral solid formulations is offered. | Taipei, Taiwan, Taiwan | 1966 |
Contract Pharmacal Corp.
|
Product development, manufacturing and packaging services | Hauppauge, United States, United States | 1971 |
Adare Pharma Solutions
|
CDMO manufacturing solid drugs | Lawrence Township, United States, United States | 2015 |
Suzhou Ze Jing Biological Pharmaceutical
|
Company developing small molecules & eukaryotic cell based recombinant protein drugs | Suzhou, China, China | 2009 |
Capsugel
|
Dosage forms are delivered for preclinical, clinical, and commercial supply. | Morristown, United States, United States | 1875 |
Glukem
|
Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. | Hyderabad, India, India | 2014 |
Vovantis Laboratories
|
Develops and manufactures novel effervescent drug delivery systems. | Vadodara, India, India | 2008 |
Business Activity of Halewood Laboratories Private Limited
Halewood Laboratories Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Halewood Laboratories Private Limited
Halewood Laboratories Private Limited is audited by SHAH & SHAH ASSOCIATES for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHAH & SHAH ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Halewood Laboratories Private Limited
Halewood Laboratories Private Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sanchit Kaushik Chaturvedi
Also directs:
Sasha Ventures Llp
|
Managing Director | 22 Dec 2011 | 14 Years 6 Months | Current |
|
Kaushik Shantilal Chaturvedi
Also directs:
Sasha Ventures Llp
|
Director | 20 Jun 2000 | 26 Years 0 Months | Current |
|
Krutin Kaushik Chaturvedi
Also directs:
Sasha Ventures Llp, Status Healthcare Private Limited
|
Managing Director | 25 Sep 2014 | 11 Years 9 Months | Current |
Financials of Halewood Laboratories Private Limited FY 2024 filings available
Halewood Laboratories Private Limited reported revenue of ₹430.29 Cr (up 20% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Halewood Laboratories Private Limited
As of FY 2024, Halewood Laboratories Private Limited's shareholding pattern shows 81.08% by promoters, 18.92% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Halewood Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2024 | Hdfc Bank Limited | ₹4.5 Cr | Open |
| 22 Mar 2023 | Hdfc Bank Limited | ₹7.88 Lakh | Open |
| 22 Mar 2023 | Hdfc Bank Limited | ₹8.68 Lakh | Open |
| 10 Nov 2021 | Axis Bank Limited | ₹82.5 Cr | Open |
| 26 Jul 2021 | Hdfc Bank Limited | ₹7.39 Lakh | Open |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Halewood Laboratories Private Limited
Halewood Laboratories Private Limited has a workforce of 473 employees as of Jan 18, 2026.
Employee Count & EPFO Data of Halewood Laboratories Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Halewood Laboratories Private Limited
GSTIN & GST Filing Data of Halewood Laboratories Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Halewood Laboratories Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Halewood Laboratories Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Halewood Laboratories Private Limited
MSME Payment Delays by Halewood Laboratories Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Halewood Laboratories Private Limited
Subsidiaries & Group Companies of Halewood Laboratories Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Halewood Laboratories Private Limited with ownership details.
MCA Filings & Documents of Halewood Laboratories Private Limited
MCA Filings & Documents of Halewood Laboratories Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Halewood Laboratories Private Limited
Recent News on Halewood Laboratories Private Limited
Frequently Asked Questions about Halewood Laboratories Private Limited
Halewood Laboratories Private Limited is an active private limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 20 June 2000 (26+ years old) and is registered under CIN U24231GJ2000PTC038236. The company has 473 employees.
Halewood Laboratories Private Limited reported revenue of ₹430.29 Cr for FY 2025 (up 20.00% YoY).
The current directors of Halewood Laboratories Private Limited are:
The primary industry of Halewood Laboratories Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Halewood Laboratories Private Limited can be reached at the registered office: 319 Gidc Industrial Estatephase Ii Vatva, Ahmedabad, Gujarat, India – 382445, or through the website halewoodlabs.com.
The authorised capital is ₹1 Cr, and the paid-up capital is ₹33 Lakh.